sulfate-polyacrylamide gels (SDS-PAGE), and the gels were fluorographed and exposed to xray film, as previously described (26) . dominant in these crosses. 75% of NFS X DBA/2 Fa hybrid mice backcrossed to NFS mice developed disease within 4 mo postinoculation. Although larger numbers of mice must be tested, the data are consistent with resistance being controlled by a single dominant gene.
Results

Pathogenicity of F-
As indicated in Table I , susceptibility to F-MuLV-induced disease does not appear to be under the control of either the Fv-1 gene, which controls the replication of FMuLV (27, 28) , the Fv-2 locus, which has previously been shown to control susceptibility to the spleen focus-forming virus (SFFV) (29) , or a gene contained within the H-2 complex. Because resistance to F-MuLV disease is dominant and appears absolute, resistant mice most likely code for a positive factor that confers resistance.
Virus-Replication in Various Strains of Mice Inoculated with F-MuL V.
Because other known murine resistance systems block replication of the input virus, it was necessary to determine whether the resistance of certain strains of mice to F-MuLV could be due to lack of replication of the virus in the spleens of these mice. Thus, splenic homogenates from both susceptible and resistant mice were analyzed for virus titer by plating on S+L-mouse cells. As shown in Table II , the titer of virus usually varied between 1 × 10 ~ and 1 × 106 focus-forming units (FFU)/ml in all strains studied except C57BL/6 mice, where the titer averaged 1 × 104 FFU/ml. The data shown in Table II represent spleens taken 4-8 wk postinoculation, but titers in resistant and susceptible strains did not differ significantly from each other or from the data in Table II when analyzed 1-4 wk postinoculation (data not presented). Also, spleen homogenates from F-MuLV-infected DBA/2 and C57BL/6 mice induced the same disease after a similar latency period in newborn NIH Swiss and BALB/c mice, indicating that an infectious dose of virus was present in the resistant strains and that the virus was not being inactivated in these mice. Thus, resistance is not due to a block in the replication of F-MuLV. possible that such viruses play a role in the induction of disease. If so, Fr-MCF virus should induce the same disease and follow the same resistance pattern as F-MuLV. Thus, Fr-MCF-1 virus isolated from the spleen of a newborn NIH Swiss mouse given F-MuLV was compared with its eeotropie parent, F-MuLV clone 201, for its ability to induce an erythroproliferative disease in adult NIH Swiss mice. It has previously been shown (14, 15, 30) that adult NIH Swiss mice are relatively resistant to disease induced by F-MuLV alone. As shown in Table III , Fr-MCF virus alone is not pathogenic in adult mice. However, the virus titer in the spleens of the Fr-MCFinfected animals was very low (~ 10 x FFU/ml). In an effort to increase the replication of Fr-MCF virus in vivo, an F-MuLV pseudotype of Fr-MCF was prepared and injected into adult NIH Swiss or DBA/2 mice. As shown in Table III , 60% of all adult NIH Swiss mice injected with the F-MuLV/Fr-MCF pseudotype developed disease within 4 mo. The disease was indistinguishable from that induced in newborn NIH Swiss mice by F-MuLV. In contrast, only 13% of aduh NIH Swiss mice injected with F-MuLV alone developed disease within 6 mo postinjection. None of the adult DBA/2 mice developed disease after infection with either F-MuLV or the F-MuLV/ Fr-MCF pseudotype. Newborn NIH Swiss mice were also infected with Fr-MCF virus. The results were the same as those obtained with adult mice: the titer of recovered virus was low (~< 101 FFU/ml) and the animals remained healthy. However, when newborn NIH Swiss mice were injected with an amphotropic virus pseudotype of Fr-MCF, 27% of the mice developed disease within 4 mo. Neither newborn NIH Swiss mice injected with amphotropic virus alone, nor newborn DBA/2 mice infected with the amphotropic virus/Fr-MCF pseudotype, nor amphotropic virus alone showed any signs of disease within 6 mo postinjection. These results indicate that Fr-MCF virus can be pathogenic in both newborn and adult NIH Swiss but not DBA/2 mice when appropriately pseudotyped, and they suggest that Fr-MCF virus is a likely intermediate in the induction of disease by F-MuLV. Mice were injected with the designated virus and killed at intervals between 2 and 6 mo postinjection. Disease and latency are defined in the legend to Table I. the availability of a specific probe for M C F gp70. M C F gp70 can be distinguished from F -M u L V gp70 by the size of its precursor (80,000 mol wt as compared with 85,000 mol wt for the F -M u L V precursor) and by its ability to be precipitated with goat anti-MCF gp70 serum that has been made M C F specific by absorption with ecotropic F-MuLV. As shown in Fig. 1A , this serum precipitates Fr-MCF gPr80 env but fails to precipitate the gPr85 env of F-MuLV.
Induction of Disease by
Infectious Virus in Spleens of
To look for infectious viruses, cell-free spleen homogenates from various F-MuLVinfected resistant and susceptible strains of mice were passaged onto N I H 3T3 fibroblasts and the cells were pulse labeled and immune precipitated with the MCFgp70-specific antiserum. As shown in Fig. 1 , N I H 3T3 fibroblasts infected with spleen homogenates from susceptible N I H Swiss and B A L B / c mice express an MCF-specific gp70 precursor (lanes B2 and C2), whereas no MCF-specific proteins could be detected in the N I H 3T3 fibroblasts infected with spleen homogenates from resistant D B A / 2 and C57BL/6 mice (lanes D2 and E2), indicating that M C F viruses are replicating in the spleens of susceptible mice but not in the spleens of resistant mice after infection with F-MuLV. Ecotropic gp70 precursors could be detected in the N I H 3T3 fibroblasts infected with spleen homogenates from all four strains (lanes B1, C1, D1, and El), which is consistent with earlier data indicating that F -M u L V is able to replicate in both susceptible and resistant strains of mice.
To determine whether the expression of M C F gp70 is directly correlated with disease, N I H 3T3 fibroblasts infected with spleen homogenates from other F-MuLVinfected susceptible and resistant strains were also analyzed for viral protein expression, and the results are summarized in Table IV 
Analysis of Cells from Uninfected Mice for Viral Protein Expression.
Although the data suggest that Fr-MCF virus plays a role in F-MuLV-induced erythroleukemia, it is not clear why certain strains of mice are resistant to disease. Immune response genes do not appear to be responsible for resistance because no differences were found in antibody levels to F-MuLV or Fr-MCF gp70 in the serum of DBA/2 and NIH Swiss mice (unpublished data). Because it was shown that MCF viruses replicate only in mice that are susceptible to F-MuLV-induced disease, we were interested in knowing whether tissues from uninfected susceptible mice but not resistant mice may be expressing endogenous MCF viruses. When cell-free bone marrow or spleen homogenates from uninfected NIH Swiss, BALB/c, DBA/2, or C57BL/6 mice were passaged onto NIH 3T3 cells, neither virus replication nor expression of MCF envelope proteins could be detected (data not shown). Tissues from the various uninfected mice were then directly examined for the expression of MCF gPr80 env by pulse labeling and immune precipitation with specific sera. As shown in Fig. 2A , bone marrow cells from uninfected NIH Swiss (panel 4) and BALB/c (panel 5) did not express any MCFspecific envelope proteins. In contrast, bone marrow cells from DBA/2 (panel 1) and C57BL/6 (panel 2) express an 80,000 mol wt protein that is specifically precipitated with a n t i -M C F gp70 serum. Bone marrow cells from B A L B / c X D B A / 2 Fa hybrid mice (panel 3) also express an M C F gPr80 env, indicating that the gene encoding this protein is d o m i n a n t or that the expression of this protein is under control of a d o m i n a n t gene. Because M C F viruses are envelope gene recombinants between ecotropic and xenotropic viruses, it is likely that the M C F gp70-specific antiserum used in this study would react with the envelope proteins encoded by the xenotropic progenitors of M C F viruses. Therefore, we will refer to the endogenous proteins detected by this antiserum as M C F / x e n o t r o p i c virus-related envelope proteins. M C F / x e n o t r o p i c virus-related envelope proteins are present not only in the cytoplasm but can also be detected on the surface of uninfected D B A / 2 and C 5 7 B L / 6 bone marrow and spleen cells as determined by iodination in the presence of lactoperoxidase (data not shown). E m b r y o fibroblast 3T3 lines derived from D B A / 2 and C 5 7 B L / 6 mice also express an M C F / x e n o t r o p i c virus-related gPr80 env (Fig. 2B , panels 1 and 2), whereas embryo fibroblasts derived from NIH Swiss and BALB/c mice do not (panels 3 and 4), which indicates that this protein is expressed in tissues outside of the hematopoietic system. The endogenous MCF/xenotropic virus-related gPrS0 env in DBA/2 fibroblasts is glycosylated and in pulse-chase experiments it can be chased into gp65 and pl5(E). In contrast to the expression of envelope proteins, no gag proteins were expressed in the DBA/2 fibroblast line (data not shown).
The data, therefore, show that mice that are resistant to disease induced by FMuLV endogenously express MCF/xenotropic virus-related envelope proteins that may somehow prevent F-MuLV or its MCF intermediate from inducing disease.
Discussion
The data reported here indicate that MCF viruses play a role in the erythroproliferative disease induced by F-MuLV. This idea is supported by the observations that expression of MCF viruses in mouse spleens can be correlated with erythroleukemia induced by F-MuLV, by the fact that Fr-MCF viruses injected as appropriate pseudotypes can cause a similar disease, and by the observation that resistance to disease induced either by F-MuLV or Fr-MCF virus is correlated with the expression of endogenous MCF/xenotropic virus-related envelope proteins that may block incoming MCF viruses by a mechanism analogous to viral interference.
Although Fr-MCF virus injected alone into susceptible strains of mice was not pathogenic, the virus was shown to be capable of inducing an erythroproliferative disease when injected as an F-MuLV or amphotropic virus pseudotype. This has been a typical observation for MCF viruses. Cloyd et al. (8) observed that AKR MCF viruses were not pathogenic in NIH Swiss mice unless those mice carried one of the Akv virus-inducing loci and were thus expressing high levels of ecotropic MuLV. Vogt (9) noted that the infectivity of Moloney MCF in vitro was increased under conditions where Moloney MCF pseudotypes were formed. Van Griensven and Vogt (10) observed that Rauscher MCF virus effectively induced foci on the spleens of infected mice only after the formation of pseudotypes with ecotropic Rauscher MuLV. Pseudotypes may facilitate the initial infection of target tissues with MCF viruses by packaging the MCF viral genomes in envelopes that are resistant to neutralizing factors present in normal mouse serum. These factors could include oncornavirusinactivating factor (31) (32) (33) (34) , shown by Haas and Patch (35) to inactivate MCF viruses recovered from x-ray-induced lymphomas of C57BL/6 mice, or antibodies specific for determinants on MCF viral envelope proteins. Once within the target tissues, MCF viruses could then replicate and spread using their own envelopes. Alternatively, the viruses used to form pseudotypes could play another role in leukemogenesis in addition to providing a different envelope for the MCF genome, such as allowing for increased proliferation of target cells for MCF viruses. However, studies by Haas and Patch (35) have indicated that phenotypically mixed pseudotype virions were required for increasing the leukemogenicity of MCF viruses and could not be replaced by a simple mixture of ecotropic and MCF viruses. Whatever the mechanism, the formation of pseudotypes with ecotropic viruses may be an important step in leukemogenesis associated with MCF viruses.
Although F-MuLV and Fr-MCF viruses are associated with erythroleukemia in certain strains of mice, other strains are resistant to the effects of these viruses. A variety of mechanisms may be responsible for the failure of an animal to develop disease after injection of a particular virus. First, the input virus may not replicate in the mouse. The Fv-1 gene (27, 28) as well as other genes (36) (37) (38) have been shown to control the replication of ecotropic viruses in certain strains of mice. Second, the input virus may not have enough available target cells in resistant strains of mice. It has been suggested that the Fv-2 gene, which controls susceptibility to disease induced by the spleen focus-forming virus, may operate through such a mechanism (39) . Mice can also be resistant because of an effective immune response against either the input virus or the virus-infected target cells. Such H-2-1inked immune response genes as Rfv-1 and Rfv-2 (40-42) as well as the non-H-2-1inked Rfv-3 (43) are thought to operate through such a mechanism. Additional mechanisms for resistance to virusinduced disease can be invoked if the input virus does not act directly but generates a second virus that is responsible for disease. In this case, the second virus may either not be generated in the resistant mouse or it may fail to replicate there either because of an effective immune response against it or because of viral interference.
Our data indicate that the resistance of certain strains of mice to disease induced by F-MuLV cannot be explained by expression of Fv-1, Fv-2, or Rfv-like genes in these mice. Any proposed mechanism must take into account the following observations: (a) resistance to F-MuLV disease is dominant; (b) resistance to F-MuLV disease is correlated with the failure to generate or replicate Fr-MCF viruses; and (c) mice resistant to F-MuLV disease are also resistant to disease induced by Fr-MCF pseudotypes. A mechanism that would best incorporate these observations would be one in which resistant strains express a factor that would block either the generation or the replication of Fr-MCF viruses. The finding that uninfected resistant strains of mice express endogenous MCF/xenotropic virus-like envelope proteins is compatible with such a mechanism. The generation of MCF viruses after infection of mice with ecotropic virus is probably occurring at a low frequency. Thus, spread and replication of MCF viruses in the organs in which they were generated would be crucial for generating a pathogenic titer of virus. If the endogenous envelope glycoproteins expressed in resistant strains of mice can block the receptors for the generated MCF viruses, their spread and replication would be prevented and a sufficient titer of virus to induce disease would never be achieved. Resistance would be dominant. The fact that endogenous MCF/xenotropic virus-related envelope proteins are not detected in susceptible strains of mice is consistent with this hypothesis. Although it is possible that MCF viruses are never generated in resistant strains of mice, the fact that pathogenic pseudotypes of Fr-MCF virus do not replicate or induce disease in strains resistant to F-MuLV disease is consistent with resistance being mediated through viral interference. This idea is supported by recent in vitro studies on the replication of MCF viruses in DBA/2 fibroblasts (R. Bassin, manuscript in preparation). Such a mechanism would be similar to that proposed by Stockert et al. (44) , who showed that inhibition of MCF virus-mediated AKR leukemogenesis could be inhibited by a nonleukemogenic MCF virus and suggested viral interference as the most likely mechanism. Although we have not been able to induce or transmit a virus encoding endogenous MCF/xenotropic virus-like envelope proteins from DBA/2 or other resistant strains, the expression of viral gp70 alone in these mice may be adequate for causing viral interference. In support of this is a recent observation by A. Rein (unpublished data) that cells infected with a defective AKR virus expressing only envelope proteins still exhibit type-specific viral interference.
The expression of an endogenous MCF/xenotropic virus-related gp70 does not appear to block disease induced by the SFFV, a virus that codes for an envelope gene product, gp52, that cross-reacts with the gp70 of Fr-MCF virus (25, 45) . NIH Swiss as well as DBA/2 mice are susceptible to SFFV-induced erythroleukemia. However, gp52 does not appear in virus particles after rescue with F-MuLV and thus does not contribute to binding of virions to receptors on the cell surface. Thus, a resistance mechanism based on viral interference would not be expected to affect susceptibility to SFFV.
We are in the process of carrying out more detailed genetic studies to determine the number and location of genes involved in resistance to F-MuLV disease and to determine the mechanism by which the expression of endogenous MCF/xenotropic virus-related envelope glycoproteins can play a role in this resistance.
Summary
In these studies, we have shown data that are consistent with the hypothesis that mink cell focus-inducing viruses (MCF) play an important role in the generation of an erythroproliferative disease developing after injection of certain strains of newborn mice with ecotropic Friend murine leukemia virus (F-MuLV). Resistance to this disease is correlated with the endogenous expression of an MCF/xenotropic virusgpT0-related protein that may interfere with the replication or spread of MCF viruses. These ideas are supported by the following observations: (a) after infection with FMuLV, only 6/13 strains of mice developed disease, and studies with crosses between susceptible and resistant strains indicated that resistance was dominant. Although FMuLV was shown to replicate equally well in all strains tested, viruses coding for MCF-specific viral envelope proteins could be detected only in the spleens of mice from strains that were susceptible to F-MuLV-induced disease and not in the spleens of mice from strains that were resistant to F-MuLV-induced disease; (b) a Friend MCF (Fr-MCF) virus isolated from the spleen of an F-MuLV-infected mouse from a susceptible strain induced the same erythroproliferative disease when injected as an appropriate pseudotype into mice from susceptible but not resistant strains of mice; and (c) resistant but not susceptible strains of mice endogenously express MCF/ xenotropic virus-related envelope glycoproteins that may be responsible for resistance by blocking receptors for MCF viruses. These results not only indicate that Fr-MCF virus is a crucial intermediate in the induction of disease by F-MuLV, but also suggest that a novel gene, either an MCF/xenotropic virus-related envelope gene or a gene controlling its expression, is responsible for resistance to erythroleukemia induced by F-MuLV.
